Investigator Initiated Multi-Site Clinical Trials

Submission Date: October 5, 2007

Funding aims to provide a vehicle for submitting grant applications for investigator-initiated multi-site Phase II or Phase III randomized, controlled clinical trials. The proposed research must address a scientifically important question, must provide valuable information to the existing knowledge base, and must have public health applicability. Research topics should be based on the NHLBI's national program plan areas of heart, lung, and blood diseases, and sleep disorders.

For complete details, visit the Investigator Initiated Multi-Site Clinical Trials webpage.